Rui Gu

Loss of TRIM31 promotes breast cancer progression through regulating K48- and K63-linked ubiquitination of p53

J. Zhang, Kai Li, P. Lin, 2021, Cell Death & Disease.

DDX39B drives colorectal cancer progression by promoting the stability and nuclear translocation of PKM2

J. Zhang, Kai Li, P. Lin, 2022, Signal Transduction and Targeted Therapy.

[Increased TRIM5 is associated with a poor prognosis and immune infiltration in glioma patients].

Kai Li, Jie Zhang, P. Lin, 2020, Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi.

DDX17 induces epithelial-mesenchymal transition and metastasis through the miR-149-3p/CYBRD1 pathway in colorectal cancer

J. Zhang, Kai Li, P. Lin, 2023, Cell Death & Disease.

DDX39B facilitates the malignant progression of hepatocellular carcinoma via activation of SREBP1-mediated de novo lipid synthesis

J. Zhang, Kai Li, P. Lin, 2023, Cellular Oncology.

DDX39B protects against sorafenib-induced ferroptosis by facilitating the splicing and cytoplasmic export of GPX4 pre-mRNA in hepatocellular carcinoma.

Qin Li, Gang Zhao, Deqiong Ou, 2024, Biochemical pharmacology.